ClinicalTrials.gg
RecruitingNCT07470528PeyronieUpdated Jul 9, 2026

Comparative Outcomes of Subtunical Microdissection and Grafting Versus Classical Plaque Incision and Grafting in Complex Peyronie's Disease

An interventional study of Subtunical microdissection and grafting and Classic plaque Incision and Grafting in Peyronie's Disease (PD), sponsored by Namik Kemal University. Recruiting at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Namik Kemal University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled May 2025, registered Mar 2026).
  • Started May 2025; still recruiting 1 year 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Non-randomized
Ages
18 Years and older
Sex
Male
01

Study summary

The goal of this clinical study is to compare two surgical techniques used for the treatment of complex Peyronie's disease. Peyronie's disease can cause penile curvature, deformity, and difficulties during sexual intercourse due to fibrotic plaques within the penile tunica albuginea. In patients with severe deformity, surgical correction is often required.

The main question this study aims to answer is whether subtunical microdissection can provide effective correction of penile curvature while preserving erectile function when compared with the classical plaque incision and grafting technique.

Participants with complex Peyronie's disease who require surgical correction will undergo either subtunical microdissection or classical plaque incision and grafting. In order to standardize the procedures, the same graft material will be used in both surgical techniques. A bovine pericardial graft will be applied in all cases, and graft size will be determined according to the geometric principles described by Egydio.

In the subtunical microdissection technique, the subtunical plane beneath the Peyronie's plaque is carefully dissected using microsurgical instruments under approximately 3.5× optical magnification with surgical loupes. In the classical technique, plaque incision is performed followed by graft reconstruction of the tunical defect.

All surgical procedures will be performed by the same surgical team using a standardized operative approach and a uniform anesthesia protocol.

Participants will be followed prospectively after surgery to evaluate penile curvature, erectile function, and patient satisfaction. The results of this study may help determine whether subtunical microdissection represents an effective and safe alternative surgical strategy for the treatment of complex Peyronie's disease.

Read the detailed description

Peyronie's disease is a fibrotic disorder of the tunica albuginea characterized by the formation of inelastic plaques within the penile shaft. These plaques may lead to penile curvature, indentation deformities, hinge effect, penile shortening, and difficulties during sexual intercourse. In patients with severe deformity or functional impairment, surgical correction remains the most effective treatment option. Plaque incision and grafting has traditionally been considered the standard surgical technique for complex Peyronie's disease, particularly in patients with severe curvature, multiplanar deformities, hourglass narrowing, or hinge effect. However, this approach requires tunical incision and graft placement, which may potentially increase the risk of postoperative erectile dysfunction, sensory changes, or graft-related complications.

Subtunical microdissection has recently been proposed as an alternative surgical approach aimed at reducing structural disruption of the tunica albuginea. In this technique, the plaque is approached through careful dissection beneath the tunical layer in order to release the deforming forces responsible for penile curvature while preserving the structural integrity of the tunica albuginea. The procedure is performed under approximately 3.5× optical magnification using surgical loupes, and the subtunical plane is meticulously dissected using microsurgical instruments. This technique allows controlled separation of fibrotic tissue from surrounding tunical structures with the aim of minimizing extensive tunical incision and reducing surgical trauma.

Despite the theoretical advantages of this technique, the clinical outcomes of subtunical microdissection have not yet been systematically compared with those of classical plaque incision and grafting in patients with complex Peyronie's disease.

The aim of this study is to compare the anatomical and functional outcomes of subtunical microdissection and classical plaque incision and grafting in patients with complex Peyronie's disease. Complex Peyronie's disease will include patients presenting with severe penile curvature, multiplanar deformity, hinge effect, hourglass deformity, or large plaques causing significant functional impairment.

In both surgical approaches, plaque incision and grafting is performed using the same graft material in order to standardize the procedure and minimize confounding variables. A bovine pericardium graft is used in all cases. In the classical technique, plaque incision is performed followed by graft placement. In the subtunical microdissection technique, plaque release is achieved through controlled subtunical dissection performed under approximately 3.5× optical magnification with microsurgical instruments. After adequate straightening is achieved, graft reconstruction is performed using the same bovine pericardial graft material.

The graft dimensions are calculated according to the geometric principles described by Egydio in order to achieve adequate defect coverage and penile straightening. All surgical procedures are performed by the same surgical team using a standardized operative technique. A uniform anesthesia protocol is also applied to all participants in order to minimize variability related to perioperative management.

Participants who meet the eligibility criteria and require surgical correction will undergo either subtunical microdissection or classical plaque incision and grafting according to the surgical approach selected by the treating surgeon. Patients will be followed prospectively after surgery to evaluate penile straightening, erectile function, and patient-reported outcomes.

The primary outcome of the study will be successful penile straightening, defined as a postoperative residual curvature of less than 30 degrees. Secondary outcomes will include changes in erectile function, patient satisfaction, penile length changes, perioperative complications, and the need for additional corrective procedures.

By comparing these two surgical approaches, this study aims to determine whether subtunical microdissection can provide effective curvature correction while potentially preserving erectile function and reducing surgical morbidity. The findings of this study may contribute to improving surgical decision-making and optimizing treatment strategies for patients with complex Peyronie's disease.

02

Conditions studied

  • Peyronie's Disease (PD)

Browse trials for

Keywords

  • Peyronie's Disease
  • Complex Peyronie's Disease
  • Subtunical Microdissection
  • Plaque Incision and Grafting
  • Penile Reconstruction
03

In context

Penile Induration

48 studies on the registry are indexed under Penile Induration; 10 are open to participants now.

This study's planned enrollment of 80 is above the median of 40 across 40 interventional studies indexed under Penile Induration.

Browse Penile Induration studies →

Lead sponsor

Namik Kemal University is the lead sponsor of 62 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Male patients aged 18 years or older
  • Diagnosis of Peyronie's disease with stable plaque and stable penile curvature for at least 3 months
  • Presence of complex Peyronie's disease including severe curvature, multiplanar deformity, hinge effect, hourglass deformity, or large plaques causing functional impairment
  • Patients requiring surgical correction with graft-based reconstruction
  • Ability to provide and comply with follow-up evaluations

Exclusion criteria

Exclusion Criteria:

  • Ossified Peyronie's plaques requiring plaque excision
  • Congenital penile curvature (congenital chordee)
  • Previous penile prosthesis implantation
  • Active phase Peyronie's disease with progressive curvature or penile pain
  • Severe erectile dysfunction not responsive to medical therapy
  • History of prior penile reconstructive surgery
  • Significant systemic illness preventing surgical treatment
  • Inability to complete postoperative follow-up assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Subtunical Microdissection and Grafting

    Participants with complex Peyronie's disease undergo subtunical microdissection and grafting. The procedure is performed under approximately 3.5× optical magnification using surgical loupes. The subtunical plane beneath the Peyronie's plaque is carefully dissected using microsurgical instruments to release deforming forces while preserving tunical integrity.

    Procedure: Subtunical microdissection and grafting

  • Active comparator
    Classic Plaque Incision and Grafting

    Participants with complex Peyronie's disease undergo classical plaque incision and grafting surgery. The Peyronie's plaque is incised, and the tunical defect is repaired using graft material to correct penile curvature.

    Procedure: Classic plaque Incision and Grafting

Interventions

  • ProcedureSubtunical microdissection and grafting

    Both surgical approaches are performed in patients with complex Peyronie's disease using the same graft material and standardized defect calculation based on geometric principles. In the classical technique, plaque incision is performed followed by graft reconstruction of the tunical defect. In the subtunical microdissection technique, the plaque is approached through careful dissection of the subtunical plane under approximately 3.5× optical magnification using microsurgical instruments in order to release deforming forces while preserving the erectile tissue.

  • ProcedureClassic plaque Incision and Grafting

    Classical plaque incision and grafting performed in patients with complex Peyronie's disease. After plaque incision, the tunical defect is reconstructed using the same graft material. Defect size is calculated according to standard geometric principles in order to achieve penile straightening.

06

What researchers measure

Primary outcomes

  1. Change in Erectile Function

    Change in erectile function measured using the International Index of Erectile Function (IIEF-5).The primary outcome of this study is the change in erectile function after Peyronie's disease surgery. The primary outcome of this study is the change in erectile function after Peyronie's disease surgery. Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The IIEF-5 score ranges from 5 to 25, with higher scores indicating better erectile function. Changes in erectile function will be evaluated by comparing baseline scores with those obtained 6 months after surgery.

    Time frame: Baseline and 6 months after surgery

  2. Successful Penile Straightening

    residual curvature \<30° Penile curvature will be assessed in a standardized manner. The degree of curvature will be measured from photographs obtained during erection induced by intracavernosal injection. The angle of curvature will be calculated using digital angle measurement on standardized photographs. The same measurement method will be used at baseline and during postoperative follow-up. To improve consistency and reduce measurement bias, curvature assessment will be performed by an investigator experienced in Peyronie's disease evaluation.

    Time frame: 6 months after surgery

Secondary outcomes

  1. Erection Hardness Score

    Change in erection hardness assessed using the Erection Hardness Score (EHS). The secondary outcome of this study is erection rigidity assessed using the Erection Hardness Score (EHS). The EHS is a validated clinical scale ranging from 1 to 4, where higher scores indicate greater erection hardness. Changes in erection hardness will be evaluated by comparing baseline values with

    Time frame: Baseline and 6 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Roadman D, Wang V, Beer A, Levine L. A contemporary assessment of the evaluation and management of patients presenting to a tertiary medical center with Peyronie's disease. Int J Impot Res. 2024 Apr;36(2):118-124. doi: 10.1038/s41443-023-00738-w. Epub 2023 Jul 19. PubMed 37468535 ↗
  • Kadioglu A, Gurcan M, Rakhmonovich AF, Dursun M. Surgical management of complex curvature in Peyronie's disease. World J Urol. 2024 Apr 30;42(1):276. doi: 10.1007/s00345-024-04936-z. PubMed 38689034 ↗
  • Egydio PH, Lucon AM, Arap S. A single relaxing incision to correct different types of penile curvature: surgical technique based on geometrical principles. BJU Int. 2004 Nov;94(7):1147-57. doi: 10.1111/j.1464-410X.2004.05220.x. No abstract available. PubMed 15541152 ↗

Individual participant data

Plan to share: No — Individual participant data will not be available to protect participant privacy.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for Oct 2026, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 10, 2026
First posted
Mar 13, 2026
StartActual
May 27, 2025
Primary completionEst.
Oct 2026
CompletionEst.
Dec 2026
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07470528
Lead sponsor
Namik Kemal University
Responsible party
Cagri DOGAN (Associate Professor, MD, Namik Kemal University) — Principal investigator
First posted
Mar 13, 2026
Start date
May 27, 2025
Primary completion
Oct 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jul 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion